In human cells, lipid droplets (LDs) predominantly contain either cholesteryl esters or triacylglycerols. This article ...

The company’s Carillon Mitral Contour System is designed to tighten the leaky valve through a minimally invasive procedure. The new funding positions the company “to continue our global ...

The company will use the funding to complete U.S. trials and commercialize its device called the Carillon Mitral Contour System, designed to repair a valve in the heart called the mitral valve.

This financing will fund the completion of the EMPOWER Trial U.S. pivotal study and support the continued commercialization of the innovative Carillon Mitral Contour System ®. “Cardiac ...

To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System Cardiac Dimensions, a leader in minimally invasive treatments ...

To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System “Cardiac Dimensions is uniquely positioned to provide a safe ...

Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s mitral valve repair device. The round was led by investment ...

To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System KIRKLAND, Wash., March 20, 2025--(BUSINESS WIRE)--Cardiac ...

The company plans to use funds to complete a U.S. pivotal study and support the commercialization of its Carillon Mitral Contour System. Kirkland, Washington–based Cardiac Dimensions designed ...

To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System “Cardiac Dimensions is uniquely positioned to provide a safe, simple ...